We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$197B
$139M 0.72%
395,351
+3,616
+0.9% +$1.29M
A icon
27
Agilent Technologies
A
$36.8B
$132M 0.69%
1,157,090
+244,007
+27% +$31M
NOW icon
28
ServiceNow
NOW
$108B
$122M 0.63%
1,163,560
+306,019
+36% +$36M
AMD icon
29
Advanced Micro Devices
AMD
$821B
$120M 0.63%
592,148
+111,080
+23% +$23.7M
XYL icon
30
Xylem
XYL
$28.7B
$116M 0.61%
974,871
+213,448
+28% +$28M
GEV icon
31
GE Vernova
GEV
$290B
$114M 0.59%
130,990
+47,346
+57% +$36.9M
KLAC icon
32
KLA
KLAC
$271B
$111M 0.58%
755,510
+535,150
+243% +$78.3M
CRM icon
33
Salesforce
CRM
$142B
$110M 0.57%
588,368
-27,218
-4% -$5.64M
TSLA icon
34
Tesla
TSLA
$1.39T
$109M 0.57%
293,400
+30,611
+12% +$12.6M
PG icon
35
Procter & Gamble
PG
$347B
$102M 0.53%
709,122
+39,614
+6% +$6.01M
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$122B
$102M 0.53%
228,915
+3,623
+2% +$1.69M
HD icon
37
Home Depot
HD
$332B
$101M 0.53%
308,386
+15,479
+5% +$5.64M
EXC icon
38
Exelon
EXC
$47B
$98.1M 0.51%
2,001,357
+798,748
+66% +$37.2M
ADI icon
39
Analog Devices
ADI
$181B
$90.7M 0.47%
285,195
-25,707
-8% -$8.18M
ON icon
40
ON Semiconductor
ON
$33.7B
$86.4M 0.45%
1,394,653
-126,667
-8% -$7.95M
WAB icon
41
Wabtec
WAB
$43.8B
$82.8M 0.43%
331,492
-115,526
-26% -$27.9M
BSX icon
42
Boston Scientific
BSX
$65.1B
$79.2M 0.41%
1,261,461
+131,623
+12% +$10.5M
ONC
43
BeOne Medicines Ltd
ONC
$32.4B
$77.1M 0.4%
259,731
+62,470
+32% +$20.2M
KEYS icon
44
Keysight
KEYS
$53.7B
$76.6M 0.4%
271,425
-44,837
-14% -$11.2M
MS icon
45
Morgan Stanley
MS
$332B
$76M 0.39%
461,887
+31,590
+7% +$5.47M
TJX icon
46
TJX Companies
TJX
$172B
$75.8M 0.39%
474,548
-41,628
-8% -$6.48M
CDNS icon
47
Cadence Design Systems
CDNS
$91B
$75.7M 0.39%
272,501
+20,579
+8% +$6.14M
MPWR icon
48
Monolithic Power Systems
MPWR
$65.3B
$75.4M 0.39%
68,944
-25,503
-27% -$27.9M
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$36.4B
$74.2M 0.39%
224,330
SCHW
50
Charles Schwab
SCHW
$178B
$71.8M 0.37%
764,475
+99,115
+15% +$9.72M

Similar funds

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.